AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 58(2), 1998, pp. 204-210
Copyright © 1998 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karunaweera, N.
Right arrow Articles by Mendis, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karunaweera, N.
Right arrow Articles by Mendis, K.
Related Collections
Right arrow Malaria
Right arrow Plasmodium
American Journal of Tropical Medicine and Hygiene, Vol 58, Issue 2, 204-210
Copyright © 1998 by American Society of Tropical Medicine and Hygiene

Research Articles


Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease

ND Karunaweera, R Carter, GE Grau, and KN Mendis

Clinical immunity to malaria was studied by quantifying the intensity of symptoms as well as by measurement of several hematologic indicators of pathology (the erythrocyte sedimentation rate [ESR], serum bilirubin, reticulocyte count, plasma tumor necrosis factor-alpha [TNF-alpha], and blood glucose levels) in 39 Plasmodium vivax malaria patients exposed to endemic malaria in southern Sri Lanka, and for comparison in 43 nonimmune patients who were residents of nonmalarious regions of the country. The intensity of 11 symptoms was scored numerically in all patients using a questionnaire. This clinical score was validated by introducing internal controls to the questionnaire, and by correlating it with the underlying pathology. Both the intensity of clinical disease as well as the degree of underlying pathology were found to be significantly lower in endemic area patients (mean clinical score = 8.8, median ESR = 8 mm) compared with the nonendemic area patients (mean clinical score = 19.0, median ESR 31.5 mm). Endemic area patients also had lower parasite densities (mean = 0.06%) than those from the nonendemic area (0.12%) (P < 0.05). However, at any parasite density, both clinical disease and pathology were significantly less in the endemic area patients (P < 0.001, for both clinical score and ESR), indicating that the clinical immunity seen in the endemic area patients was a true tolerance of parasites. Although plasma TNF-alpha levels were elevated in both groups of patients, they were significantly higher in the nonendemic area patients than in patients from the endemic area (P < 0.01). Furthermore, at comparable levels of plasma TNF-alpha, nonendemic area patients had both a higher intensity of clinical disease and an underlying pathology than those from the endemic area, suggesting that if TNF-alpha is indeed a mediator of clinical disease, the endemic area patients may be tolerant to its effects. Hypoglycemia was not observed in any of these P. vivax patients despite some with high levels of plasma TNF-alpha.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
K. K. G. SCOPEL, M. D. SILVA-NUNES, R. S. MALAFRONTE, E. M. BRAGA, and M. U. FERREIRA
VARIANT-SPECIFIC ANTIBODIES TO MEROZOITE SURFACE PROTEIN 2 AND CLINICAL EXPRESSION OF PLASMODIUM FALCIPARUM MALARIA IN RURAL AMAZONIANS
Am J Trop Med Hyg, June 1, 2007; 76(6): 1084 - 1091.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
H. C. HAPUARACHCHI, M. Y. D. DAYANATH, K. B. A. T. BANDARA, S. ABEYSUNDARA, W. ABEYEWICKREME, N. R. DE SILVA, S. Y. HUNT, and C. H. SIBLEY
POINT MUTATIONS IN THE DIHYDROFOLATE REDUCTASE AND DIHYDROPTEROATE SYNTHASE GENES OF PLASMODIUM FALCIPARUM AND RESISTANCE TO SULFADOXINE-PYRIMETHAMINE IN SRI LANKA
Am J Trop Med Hyg, February 1, 2006; 74(2): 198 - 204.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. P. MUEHLENBEIN, J. ALGER, F. COGSWELL, M. JAMES, and D. KROGSTAD
THE REPRODUCTIVE ENDOCRINE RESPONSE TO PLASMODIUM VIVAX INFECTION IN HONDURANS
Am J Trop Med Hyg, July 1, 2005; 73(1): 178 - 187.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
F. Martini, M. G. Paglia, C. Montesano, P. J. Enders, M. Gentile, C. D. Pauza, C. Gioia, V. Colizzi, P. Narciso, L. P. Pucillo, et al.
V{gamma}9V{delta}2 T-Cell Anergy and Complementarity-Determining Region 3-Specific Depletion during Paroxysm of Nonendemic Malaria Infection
Infect. Immun., May 1, 2003; 71(5): 2945 - 2949.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J.-Y. SEOH, M. KHAN, S.-H. PARK, H.-K. PARK, M.-H. SHIN, E.-H. HA, B.-E. LEE, K. YOO, H.-S. HAN, S. OH, et al.
SERUM CYTOKINE PROFILES IN PATIENTS WITH PLASMODIUM VIVAX MALARIA: A COMPARISON BETWEEN THOSE WHO PRESENTED WITH AND WITHOUT HYPERPYREXIA
Am J Trop Med Hyg, January 1, 2003; 68(1): 102 - 106.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
M. C. Bruce, C. A. Donnelly, M. P. Alpers, M. R. Galinski, J. W. Barnwell, D. Walliker, and K. P. Day
Cross-Species Interactions Between Malaria Parasites in Humans
Science, February 4, 2000; 287(5454): 845 - 848.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. J. Mackinnon, D. M. Gunawardena, J. Rajakaruna, S. Weerasingha, K. N. Mendis, and R. Carter
Quantifying genetic and nongenetic contributions to malarial infection in a Sri Lankan population
PNAS, November 7, 2000; 97(23): 12661 - 12666.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society of Tropical Medicine and Hygiene.